All Stories

  1. Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  2. Supplementary Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  3. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  4. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  5. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  6. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  7. Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  8. Caveats of assessing incidence trends using publicly available registry data
  9. Opportunities and challenges in pooling health-related quality-of-life data for prediction modeling in breast cancer across Europe: lessons from the EORTC BALANCE project
  10. Langzeit-Organtoxizität von onkologischen Therapien
  11. Todesursachenspezifische Mortalität in den ersten Jahren nach Diagnose einer Krebserkrankung
  12. Combined lifestyle factors on mortality and cardiovascular disease among cancer survivors: a systematic review and meta-analysis of cohort studies
  13. Combined healthy lifestyle factors and psychosocial outcomes among cancer survivors: a systematic review and meta-analysis
  14. Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  15. Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  16. Supplementary Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  17. Supplementary Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  18. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
  19. Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  20. Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  21. Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  22. Table 1 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  23. Table 1 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  24. Table 2 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  25. Table 2 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  26. A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  27. Data from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  28. Data from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  29. Supplementary Figures 1-4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  30. Supplementary Figures 1-4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  31. Supplementary Tabe 1 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  32. Supplementary Tabe 1 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  33. Supplementary Table 2 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  34. Supplementary Table 2 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  35. Supplementary Table 3 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  36. Supplementary Table 3 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  37. Supplementary Table 4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  38. Supplementary Table 4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  39. Supplementary Table 5 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  40. Supplementary Table 5 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  41. Supplementary Table 6 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  42. Supplementary Table 6 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  43. Supplementary Table Legends from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  44. Supplementary Table Legends from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  45. Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14–24 Years Post-Diagnosis: A Population-Based Study
  46. The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020
  47. Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
  48. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
  49. Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
  50. Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options
  51. Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  52. Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
  53. Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation
  54. Inpatient rehabilitation therapy among colorectal cancer patients – utilization and association with prognosis: a cohort study
  55. Health-Related Quality of Life in Very Long-Term Cancer Survivors 14–24 Years Post-Diagnosis Compared to Population Controls: A Population-Based Study
  56. Correction to: Association of laparoscopic colectomy versus open colectomy on the long‑term health‑related quality of life of colon cancer survivors
  57. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
  58. Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study
  59. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
  60. Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany
  61. The relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: A systematic review
  62. Prevalence and severity of long-term physical, emotional, and cognitive fatigue across 15 different cancer entities
  63. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk
  64. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
  65. Health‐related quality of life in long‐term prostate cancer survivors after nerve‐sparing and non‐nerve‐sparing radical prostatectomy—Results from the multiregional PROCAS study
  66. Physical activity and long-term fatigue among colorectal cancer survivors – a population-based prospective study
  67. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
  68. Überleben nach primär metastasiertem Brustkrebs
  69. Physical activity and long-term quality of life among colorectal cancer survivors - a population-based prospective study
  70. Beiträge der Epidemiologie bei der Sekundärprävention von Krebserkrankungen
  71. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
  72. Mendelian randomization of circulating polyunsaturated fatty acids and colorectal cancer risk
  73. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry
  74. Correction to: The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study
  75. Cancer-Related Fatigue: Causes and Current Treatment Options
  76. Association of laparoscopic colectomy versus open colectomy on the long-term health-related quality of life of colon cancer survivors
  77. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study
  78. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
  79. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
  80. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015
  81. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
  82. Age at Diagnosis and Sex Are Associated With Long-term Deficits in Disease-Specific Health-Related Quality of Life of Survivors of Colon and Rectal Cancer: A Population-Based Study
  83. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives
  84. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
  85. Two truncating variants in FANCC and breast cancer risk
  86. Beiträge der Epidemiologie bei der Primärprävention von Krebserkrankungen
  87. Health‐related quality of life in long‐term survivors with localised prostate cancer by therapy—Results from a population‐based study
  88. The association of cancer‐related fatigue with all‐cause mortality of colorectal and endometrial cancer survivors: Results from the population‐based PROFILES registry
  89. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
  90. Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries
  91. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany
  92. Genome-wide association study of germline variants and breast cancer-specific mortality
  93. Return to work after cancer. A multi-regional population-based study from Germany
  94. Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls – a population-based study
  95. Cardiovascular Risk Factors Associated With Venous Thromboembolism
  96. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
  97. Discovery of common and rare genetic risk variants for colorectal cancer
  98. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk
  99. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
  100. Correction to: Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review
  101. The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life
  102. Novel Common Genetic Susceptibility Loci for Colorectal Cancer
  103. “Still a Cancer Patient”—Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors
  104. Erratum: Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
  105. OUP accepted manuscript
  106. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany
  107. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk
  108. Helicobacter pylori Infection and Gastric Cancer Risk: Evaluation of 15 H. pylori Proteins Determined by Novel Multiplex Serology
  109. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk
  110. Overweight, obesity and risk of work disability: a cohort study of construction workers in Germany
  111. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study
  112. Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System
  113. Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas
  114. Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined
  115. Body Mass Index and Premature Mortality in Physically Heavily Working Men???A Ten-Year Follow-Up of 20,000 Construction Workers
  116. Recent Major Progress in Long-Term Cancer Patient Survival Disclosed by Modeled Period Analysis
  117. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?
  118. Up-to-date monitoring of childhood cancer long-term survival in Europe: central nervous system tumours
  119. Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas
  120. Gender differences in colorectal cancer: implications for age at initiation of screening
  121. Cancer survival in Germany and the United States at the beginning of the 21st century: An up-to-date comparison by period analysis
  122. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based study
  123. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis
  124. Construction work and risk of occupational disability: a ten year follow up of 14 474 male workers
  125. Further Enhanced Monitoring of Cancer Patient Survival by Stage-Adjusted Period Analysis
  126. Persistence of Restrictions in Quality of Life From the First to the Third Year After Diagnosis in Women With Breast Cancer
  127. Reduction of clinically manifest colorectal cancer by endoscopic screening: empirical evaluation and comparison of screening at various ages
  128. Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed
  129. Long-Term Survival Rates of Patients With Prostate Cancer in the Prostate-Specific Antigen Screening Era: Population-Based Estimates for the Year 2000 by Period Analysis
  130. Quality of Life in Patients With Colorectal Cancer 1 Year After Diagnosis Compared With the General Population: A Population-Based Study
  131. Age, alcohol consumption, and all-cause mortality
  132. Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient
  133. An alternative approach to age adjustment of cancer survival rates
  134. All-cause and cause specific mortality in a cohort of 20 000 construction workers; results from a 10 year follow up
  135. Epidemiology in aging research
  136. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis
  137. Modification of SAS macros for a more efficient analysis of relative survival rates
  138. Is Helicobacter pylori Infection a Necessary Condition for Noncardia Gastric Cancer?
  139. Provider Delay Among Patients With Breast Cancer in Germany: A Population-Based Study
  140. Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer
  141. Risk of gastric cancer among smokers infected withHelicobacter pylori
  142. Long-lasting reduction of risk of colorectal cancer following screening endoscopy
  143. Socio-demographic factors, health behavior and late-stage diagnosis of breast cancer in Germany
  144. Environmental Chemical Exposures and Risk of Herpes Zoster
  145. Effects of Short Interpregnancy Intervals on Small-for-Gestational Age and Preterm Births
  146. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality
  147. Early Retirement Due to Permanent Disability in Relation to Smoking in Workers of the Construction Industry
  148. Body weight, pre-existing disease, and all-cause mortality in a cohort of male employees in the German construction industry
  149. Disorders of the Back and Spine in Construction Workers
  150. Chronic respiratory disease morbidity in construction workers: patterns and prognostic significance for permanent disability and overall mortality
  151. Distribution, Determinants, and Prognostic Value of γ-Glutamyltransferase for All-Cause Mortality in a Cohort of Construction Workers from Southern Germany
  152. The association between alcohol consumption and all-cause mortality in a cohort of male employees in the German construction industry.
  153. Smoking patterns and mortality attributable to smoking in a cohort of 3528 construction workers